Potassium Citrate has 10 known drug interactions based on U.S. FDA drug labeling data. Of these, 3 are contraindicated combinations that should be avoided entirely. 7 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Amiloride, Spironolactone, Triamterene. Patients taking Potassium Citrate should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 10
- Contraindicated
- 3
- Major
- 7
Contraindicated (3)
- Potassium Citrate + Amiloride— Concomitant administration can produce severe hyperkalemia and should be avoided.
- Potassium Citrate + Spironolactone— Concomitant administration can produce severe hyperkalemia and should be avoided.
- Potassium Citrate + Triamterene— Concomitant administration can produce severe hyperkalemia and should be avoided.
Major (7)
- Potassium Citrate + Aldosterone— 7 DRUG INTERACTIONS The following drug interactions may occur with potassium citrate: Potassium-sparing diuretics: conco…
- Potassium Citrate + Aliskiren— Monitor for hyperkalemia. Drug inhibits aldosterone production and produces potassium retention.
- Potassium Citrate + Angiotensin Ii— Produce potassium retention by inhibiting aldosterone production; closely monitor potassium levels.
- Potassium Citrate + Eplerenone— Monitor for hyperkalemia. Drug inhibits aldosterone production and produces potassium retention.
- Potassium Citrate + Mao Inhibitors— Produce potassium retention by inhibiting aldosterone production; closely monitor potassium levels.
- Potassium Citrate + Nonsteroidal Anti-Inflammatory Drugs (Nsaids)— May produce potassium retention; closely monitor potassium levels during concomitant use.
- Potassium Citrate + Nsaids— Monitor for hyperkalemia. NSAIDs reduce renal prostaglandin E synthesis and impair the renin-angiotensin system.